Hepatoma

Hepatoma is a primary malignant tumor of the liver that is typically associated with hepatitis or cirrhosis. It is also known as hepatocellular carcinoma (HCC).

Etiology

The exact cause of hepatoma is unknown, but it is often associated with damage to the liver such as cirrhosis and hepatitis. Other risk factors include alcohol abuse, obesity, and diabetes.

Symptoms

Symptoms of hepatoma may include jaundice, abdominal pain, weight loss, loss of appetite, and nausea. However, many people with hepatoma do not have symptoms until the disease is advanced.

Diagnosis

Hepatoma is diagnosed through a combination of medical history, physical examination, and imaging tests such as ultrasound, CT scan, or MRI. A biopsy may also be performed to confirm the diagnosis.

Treatment

Treatment options for hepatoma include surgery, chemotherapy, radiation therapy, and targeted therapy. The choice of treatment depends on the stage of the disease, the patient's overall health, and the patient's personal preferences.

Prognosis

The prognosis for hepatoma varies widely depending on the stage of the disease at diagnosis, the patient's overall health, and the effectiveness of treatment. Early detection and treatment can significantly improve the prognosis.

Prevention

Prevention strategies for hepatoma include avoiding risk factors such as alcohol abuse, maintaining a healthy weight, and getting vaccinated against hepatitis B and C.

See also

• Liver cancer
• Hepatitis
• Cirrhosis
• Alcohol abuse
• Obesity
• Diabetes

Hepatoma Resources
Latest articles Most recent articles Ongoing trials	Wikipedia